medline.ch Onkologie Urologische Tumoren

	Risk Signals of Antibody-Drug Conjugates in Bladder Cancer: A Real-World FAERS Study. Clin Epidemiol Liu J, Li G, Yang J, Sun B, Guo S. PMID: 41341429 [PubMed]
	Case Report: Clinical pathological characteristics, diagnosis, and treatment analysis of eosinophilic solid and cystic renal cell carcinoma: experience from a five-case series. Front Oncol Zi GR, Feng RL, Guo X, Zhang DJ, He DL, Ke CX. PMID: 41341398 [PubMed]
	Prospective trial on focal treatment with hemigland brachytherapy in low-risk prostate cancer: A negative study. J Contemp Brachytherapy Gutiérrez C, Villafranca E, Ferrer M, Sola A, Slocker A, Ventura M, Visus I, Pino F, Barrado M, Illas M, Najjari D, Fuentemilla N, Araguás P, Pellejero S, Garin O. PMID: 41340828 [PubMed]
	A Randomised Clinical Trial Comparing Two Biopsy Templates and Follow-up Schedules for Men on Active Surveillance for Low-risk Prostate Cancer: SAMS. Eur Urol Open Sci Robinson D, Maljkovic J, Genell A, Carlsson S, Holmberg E, Bratt O, SAMS Trial Group. PMID: 41340679 [PubMed]
	A novel biochip-based liquid biopsy for extracellular vesicle RNA detection in prostate cancer. Cancer Biol Ther Diao Y, Nan A, Li R, Ding T, Li Z, Wang J, Zhu B, Li J, Yang L, Zhou L, Liu J, Hao X. PMID: 41340217 [PubMed - indexed for MEDLINE]
	Single-cell sequencing in bladder cancer: new insights from tumor cell diversity to individualized treatment strategies. Cancer Cell Int Liufu C, Ye S, Yin C, Zhu T, Jiang J, Wang Y, Shi B. PMID: 41339886 [PubMed - as supplied by publisher]
	Global, regional, and national burdens of bladder cancer attributable to high fasting plasma glucose from 1990 to 2021, with future forecasts to 2050: a systematic analysis for the global burden of disease study 2021. BMC Cancer Lan K, Zhang Y, Luo Y, Hong T, Liu X, Hu Y, Lin W, Hong X, Zhang Y. PMID: 41339802 [PubMed - as supplied by publisher]
	The association between lower urinary tract symptoms and urinary tract infections, and subsequent prostate cancer workup: a nationwide population-based case-control study. Br J Cancer Widding JL, Stroomberg HV, Dalton SO, Brasso K, Røder A, Larsen SB. PMID: 41339755 [PubMed - as supplied by publisher]
	Age-related survival disparities in advanced renal cell carcinoma following immune checkpoint inhibitor adoption using SEER and meta-analysis. Sci Rep Al-Danakh A, Jian Y, Yang L, Safi M, Zhu X, Alradhi M, Askar B, Baldi S, Chen Q, Wang S, Yang D. PMID: 41339655 [PubMed - as supplied by publisher]
	A Prostatic Extra-Gastrointestinal Stromal Tumor Treated by Surgery: A Case Report with 7-Year Follow-Up and Review of Literature. Arch Esp Urol Yang E, Jing S, Fan G, Fan N, Zhang Y, Zhang W, Wang Y, Sun X, Wang Z. PMID: 41339245 [PubMed - indexed for MEDLINE]
	Case Report of Rare Metastasis of Renal Cell Carcinoma to the Bladder: A New Hypothesis and Literature Review. Arch Esp Urol Manav AN. PMID: 41339243 [PubMed - indexed for MEDLINE]
	Effect of Nutritional-Psychological Dual-Wheel-Driven Enhanced Recovery after Surgery Nursing on the Prognosis of Patients with Bladder Cancer: A Retrospective Cohort Study. Arch Esp Urol Guo J, Xue J, Yu Z, Dong J, Liu M. PMID: 41339239 [PubMed - indexed for MEDLINE]
	Effect of Continuity of Care on Cancer-Related Fatigue, Self-Care Ability and Fear of Recurrence in Patients with Intravesical Chemotherapy after Transurethral Resection of Bladder Tumors. Arch Esp Urol Huang Z, Cai Y, Zhong H, Zhou L. PMID: 41339235 [PubMed - indexed for MEDLINE]
	Diagnostic Values of Serum Matrix Metalloproteinase-9 and Nuclear Matrix Protein 22 for Bladder Cancer. Arch Esp Urol Chen L, He J. PMID: 41339233 [PubMed - indexed for MEDLINE]
	Efficacy Evaluation of Multi-Slice Spiral CT in Patients with Muscle-Invasive Bladder Cancer after Neoadjuvant Chemotherapy with Gemcitabine and Cisplatin. Arch Esp Urol Guo H, Zhang L, Xu F, Liu P. PMID: 41339230 [PubMed - indexed for MEDLINE]
	Metabolomics in Prostate Cancer: A Minimally Invasive Method Using Urine after Prostatic Massage to Predict Gleason Grade. Arch Esp Urol Panach-Navarrete J, González-Marrachelli V, Morales-Tatay JM, García-Morata F, Sales-Maicas MÁ, Monleón-Salvado D, Martínez-Jabaloyas JM. PMID: 41339219 [PubMed - indexed for MEDLINE]
	Focal Therapy for Prostate Cancer: Available Technologies, Patient Selection, Follow-Up Protocols and Reported Outcomes. Arch Esp Urol Pow-Sang J, Bechara GR. PMID: 41339218 [PubMed - indexed for MEDLINE]
	Improving ovarian cancer risk assessment using a machine learning model developed on data from the Prostate Lung Colorectal Ovarian Cancer Screening Trial. Int J Gynecol Cancer Sarayi SMMJ, Tammemägi M, Meyer LA, Toumazis I. PMID: 41339202 [PubMed - as supplied by publisher]
	Mapping heterogeneity in the tumor microenvironment of renal cell carcinoma through single-cell omics. Trends Cancer Gok Yavuz B, Khanmammadova N, Majeed Z, Ali MIH, Hasanov M, Bilen MA, Singer EA, Hasanov E. PMID: 41339185 [PubMed - as supplied by publisher]
	European Registry of Next Generation Imaging in Advanced Prostate Cancer (RING): protocol for an international, prospective registry study. BMJ Open Chernysheva D, Fanti S, Bjartell A, Afferi L, Breda A, Palou J, Padhani AR, Sanguedolce F. PMID: 41338644 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 174238

Seite 1 von 8712

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung